Institutional Sign In

Go

GlaxoSmithKline Czech Republic - Pre-Tax Profit

GlaxoSmithKline CR`s Pre-Tax Profit reached 89.0 CZK mil in 2017. This is 66.5 % more than in the previous year.

$1.99

Buy Pre-Tax Profit data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ...             56.5 35.3 38.6 50.2 44.0    
Bayer Czech Republic CZK mil ... ... ...                 195 102 123 135 162    
GlaxoSmithKline Czech Republic CZK mil ... ... ...                 286 212 163 117 156    
Merck Czech Republic CZK mil ... ...                   59.7 71.8 42.1 46.1 87.2    
Novartis Czech Republic CZK mil                       51.2 50.0 52.3 89.2 105    
Pfizer Czech Republic CZK mil ... ...                   285 59.6 178 165 91.9    
Roche Czech Republic CZK mil ... ... ...                 82.4 70.7 182 133 80.6   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               63.6 52.0 78.4 1.59 87.2    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... 16.2 17.2 17.4 19.6    
Walmark CZK mil ... ... ...                 235 19.0 -1.46 61.8 -725